TotalMarketCap

Editas Medicine

EDITNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$390.861 M

$2.55 -6.43%

Close of 6 Nov 2026

As of 6 Nov 2026, Editas Medicine (EDIT) has a market capitalization of $390.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$40.5M

#2781 by revenue

Earnings

-$160.1M

Loss-making

Shares outstanding

153,580,035

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #66RegenxbioRGNX$487.2M
  2. #67Electra TherapeuticsETRA$449.4M
  3. #68Editas MedicineEDIT$390.9M
  4. #69Tectonic TherapeuticTECX$382.0M
  5. #70Allogene TherapeuticsALLO$380.0M

What if Editas Medicine were worth as much as…

Open the what-if tool →

Gold $28.2T

$183,857.71

Per share 72,243× higher

Bitcoin $1.53T

$9,948.22

Per share 3,909× higher

Apple $5.02T

$32,659.08

Per share 12,833× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Editas Medicine are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.